Biogen
BIIB
#864
Rank
NZ$39.41 B
Marketcap
$270.50
Share price
-0.07%
Change (1 day)
-29.46%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Biogen (BIIB) - Cost to borrow shares

Latest borrow fee for Biogen (BIIB) shares on Interactive Brokers: 0.4081% (annualized)

Shares available to borrow: 4500000

The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock.
Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.

Biogen (BIIB) - cost to borrow in the last 7 days chart

Biogen (BIIB) - number of shares available to borrow in the last 7 days

Biogen (BIIB) - cost to borrow from 2024 to 2023

Biogen (BIIB) - number of shares available to borrow from 2024 to 2023

Cost to borrow for shares of similar companies or competitors

Company Cost to borrow (% year) Shares available Country
0.4009%3.9 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.3871%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.4081%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.4081%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.2553%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
64.8578%0 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.485%2.2 M๐Ÿ‡ซ๐Ÿ‡ท France
0.25%0.5 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.4081%2.3 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.4081%2.3 M๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands